Lab sample chain-of-custody documentation and tracking SaaS
The Opportunity
As synthetic biology research accelerates (evidenced by NCBS experiments on artificial life), hundreds of labs will need to track, document, and audit the provenance of biological samples through multi-stage experiments. Current lab notebooks and spreadsheets cannot provide tamper-proof audit trails, regulatory compliance records, or real-time visibility into sample mutations across iterations — critical for reproducibility and IP protection.
Market Size
₹180 Cr addressable market — 800+ research institutions in India × ₹20-30 L annual SaaS spend on lab management tools, growing 35% annually as synthetic biology funding accelerates
Business Model
Subscription SaaS (per-lab, per-researcher, or per-sample-batch). Freemium tier for academic labs, premium for biotech companies. API integrations with lab equipment (microscopes, sequencers, incubators). White-label for institutional licensing.
1) Monthly subscriptions: ₹15-40K per lab depending on researcher count. 2) Premium audit/compliance modules: ₹5-10K/month. 3) Data export + regulatory reporting: ₹2-5K per report. 4) API access for equipment vendors: ₹10-25K annual per integration.
Your 30-Day Action Plan
Conduct 10 deep interviews with PhD candidates and lab heads at NCBS, IISc, IIT-B biotech labs. Document exact pain points in sample tracking, failed experiments, and compliance audits.
Map regulatory requirements: DBT guidelines for synthetic biology research, IP documentation needs, reproducibility standards. Identify 2-3 must-have features that differentiate from generic LIMS.
Build clickable prototype showing sample lineage tracking, automated audit logs, and researcher role-based access. Validate with 3 pilot labs (offer 3-month free access in exchange for feedback).
Secure first 2 paying customers (₹2-3K/month each). Develop integration roadmap with equipment vendors (e.g., microscope manufacturers used at NCBS).
Compliance & Regulatory Angle
GST 18% on SaaS. DSIR recognition for research tools (optional, accelerates adoption). Data residency compliance: host on Indian servers (AWS Mumbai). Optional: ISO 27001 certification for biotech compliance features. No licensing required.
Ready to Act on This Opportunity?
Generate a 7-step execution plan — validate the market, build the MVP, model the financials, map the risks, and ship in 30 days.